Home NDC 64679-171 ROPINIROLE HYDROCHLORIDE
Product NDC 64679-171
11-digit product format 646790171
Labeler code 64679
Product ID 64679-171_e5aa4d3e-9925-4d24-93ed-69a16f88601c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ropinirole hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Wockhardt USA LLC.
Application ANDA079050
Marketing category ANDA
Marketing start 2008-05-29
Marketing end 0000-00-00
Substance ROPINIROLE HYDROCHLORIDE
Active strength 1 mg/1
Pharmacologic classes Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 105 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-171-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-171-03 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-171-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-171-04 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-171-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-171-03 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-171-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-171-04 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-171-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-171-03 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-171-02 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-171-04 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-171-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-171-03 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-171-02 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-171-04 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-171-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-171-03 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-171-02 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-171-04 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-171-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-171-03 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-171-02 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-171-04 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-171-01 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-171-03 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-171-02 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-171-04 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-171-01 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-171-03 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-171-02 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-171-04 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-171-01 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-171-03 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-171-02 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-171-04 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-171-04 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-171-02 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-171-03 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-171-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-171-04 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-171-02 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-171-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-171-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-171-04 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-171-02 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-171-03 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-171-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A079050-001 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 A079050-002 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 A079050-003 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 A079050-004 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 A079050-005 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 A079050-006 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 A079050-007 ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 7 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 287 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-006 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079050-007 ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-006 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079050-007 ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-006 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079050-007 ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-006 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079050-007 ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-006 ROPINIROLE HYDROCHLORIDE EQ 4MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079050-007 ROPINIROLE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-05-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079050-001 ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE TABLET / ORAL AB 2008-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079050-002 ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE TABLET / ORAL AB 2008-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079050-003 ROPINIROLE HYDROCHLORIDE EQ 1MG BASE TABLET / ORAL AB 2008-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079050-004 ROPINIROLE HYDROCHLORIDE EQ 2MG BASE TABLET / ORAL AB 2008-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079050-005 ROPINIROLE HYDROCHLORIDE EQ 3MG BASE TABLET / ORAL AB 2008-05-29 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 8 · 287 observed states.
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 64679-171-01 2024-11-15 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-02 2024-11-15 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-03 2024-11-15 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-04 2024-11-15 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-01 2020-01-31 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-02 2020-01-31 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-03 2020-01-31 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997 64679-171-04 2020-01-31 These highlights do not include all the information needed to use ROPINIROLE TABLETS safely and effectively. See full prescribing information for ROPINIROLE TABLETS. ROPINIROLE tablets, for oral use Initial U.S. Approval: 1997
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ROPINIROLE HYDROCHLORIDE ACTIVE INGREDIENT D7ZD41RZI9 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 ROPINIROLE ACTIVE MOIETY 030PYR8953 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 CARMINIC ACID INACTIVE INGREDIENT CID8Z8N95N ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [WOCKHARDT USA LLC.] 2